Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
By Amer Ghavanini
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Amer Ghavanini
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 200
Description
A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.
| Episode | Date |
|---|---|
|
Drugs for Migraine Prophylaxis
|
Jun 14, 2026 |
|
Intrathecal Mesenchymal Stem Cells in Progressive MS: The SMART-MS Trial
|
Jun 07, 2026 |
|
Neurologic Adverse Events from Immune Checkpoint Inhibitors
|
May 31, 2026 |
|
Anti-KLHL11 Encephalitis
|
May 31, 2026 |
|
Sleep Neurology: Pearls and Pitfalls for the Practising Neurologist
|
May 25, 2026 |
|
Tavapadon as Adjunctive Therapy for Parkinson Disease - TEMPO-3 Trial
|
May 24, 2026 |
|
Identifying Autoimmune Encephalitis in Rapidly Progressive Dementia
|
May 24, 2026 |
|
Heterogeneity in Primary CNS Vasculitis
|
May 18, 2026 |
|
Neurological Involvements of Multiple Myeloma: A Comprehensive Clinical Review
|
May 12, 2026 |
|
2026 European Guidelines for Management of Aneurysmal Subarachnoid Haemorrhage
|
May 10, 2026 |
|
Neurological Assessment and Management of Autonomic Failure
|
May 09, 2026 |
|
Intracranial Arterial Dolichoectasia: A Comprehensive Review
|
May 09, 2026 |
|
N-Acetylcysteine in Ischemic Stroke: A Systematic Review
|
May 03, 2026 |
|
Thiamin and Folic Acid for Cognitive Impairment in Hemodialysis Patients
|
May 02, 2026 |
|
Advances in the Treatment of Autoimmune Nodopathy
|
Apr 26, 2026 |
|
Advances in Guillain-Barré Syndrome: Diagnosis, Biomarkers, and Management
|
Apr 26, 2026 |
|
GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
|
Apr 22, 2026 |
|
Anti-Amphiphysin Antibody Positive Autoimmune Syndrome
|
Apr 20, 2026 |
|
Shingles Vaccination and Reduced Dementia Risk
|
Apr 19, 2026 |
|
Approach to Asymptomatic HyperCKemia - EAN Guidelines
|
Apr 19, 2026 |
|
Predictive T-Cell Biomarkers for Checkpoint Inhibitor Response in PML
|
Apr 15, 2026 |
|
Practical Strategies for SCIg Maintenance Therapy in CIDP Patients
|
Apr 13, 2026 |
|
Treatment of Spinal Cavernous Malformations: A Systematic Review
|
Apr 12, 2026 |
|
Augmenting Diagnostic Yield From Genomic Testing in Neurological Diseases
|
Apr 10, 2026 |
|
Spinal and Bulbar Muscular Atrophy: Pathogenesis and Therapeutic Horizons
|
Apr 06, 2026 |
|
Phase 3 Trial of Brepocitinib in Dermatomyositis
|
Apr 06, 2026 |
|
Are Patients with Essential Tremor at Increased Risk of Parkinson's Disease?
|
Mar 29, 2026 |
|
Efficacy of Hyperbaric Oxygen in Neurological Disorders
|
Mar 28, 2026 |
|
Recent Advances in Targeted Therapies for Adult Gliomas
|
Mar 28, 2026 |
|
Modafinil for Excessive Daytime Sleepiness in Narcolepsy: A Meta-Analysis
|
Mar 24, 2026 |
|
The European Medicines Agency's Assessment of Lecanemab and Donanemab for Alzheimer’s Disease
|
Mar 23, 2026 |
|
The Vital Role of PET/CT in NF1 Cancer Surveillance
|
Mar 22, 2026 |
|
A Diagnostic Assay for Multiple Sclerosis Based on EBV
|
Mar 17, 2026 |
|
Radiologically Isolated Syndrome: A Practical Clinical Guide
|
Mar 15, 2026 |
|
Stenting vs. Shunting for Sight-Threatening Intracranial Hypertension
|
Mar 15, 2026 |
|
AI-Driven Biomarkers in Neurology: A Narrative Review
|
Mar 10, 2026 |
|
Pompe Disease - Advances in Diagnosis and Management
|
Mar 08, 2026 |
|
Hallmarks of Secondary Headaches
|
Mar 07, 2026 |
|
Del-desiran Therapy for Myotonic Dystrophy Type 1
|
Mar 04, 2026 |
|
Long-Term Efficacy and Safety of Tofersen in SOD1-ALS Patients
|
Mar 03, 2026 |
|
Movement Disorders and Oculomotor Abnormalities in Whipple's Disease
|
Mar 02, 2026 |
|
Acute Disseminated Encephalomyelitis (ADEM): Review
|
Mar 01, 2026 |
|
A refresher on abnormal spontaneous EMG activities
|
Feb 27, 2026 |
|
A Review of Posterior Reversible Encephalopathy Syndrome (PRES)
|
Feb 26, 2026 |
|
General neurologists guide for diagnosis of atypical parkinsonian disorders
|
Feb 25, 2026 |
|
Refractory, intensive care–dependent NMDAR encephalitis
|
Feb 24, 2026 |
|
LRP4 Antibodies in Suspected Myasthenia Gravis Diagnosis
|
Feb 23, 2026 |
|
Autoimmune encephalitis during the COVID-19 pandemic
|
Feb 22, 2026 |
|
Dermatomyositis: Modern Diagnostic Paradigms
|
Feb 11, 2026 |
|
The HTLV-1 Neurological Complex: Beyond Myelopathy
|
Feb 10, 2026 |
|
Alpha-Lipoic Acid Efficacy in Managing Diabetic Polyneuropathy Symptoms
|
Feb 09, 2026 |
|
Etiological Screening Strategies for Small Fiber Neuropathy
|
Feb 08, 2026 |
|
Tenecteplase in acute central retinal artery occlusion, a phase 3 Clinical Trial
|
Feb 04, 2026 |
|
How to use blood-based biomarkers to diagnose Alzheimer’s disease
|
Feb 03, 2026 |
|
Brief Review - 2026 Guidelines for Early Management of Acute Ischemic Stroke
|
Feb 01, 2026 |
|
Multifocal Motor Neuropathy: Clinical Features, Diagnosis, and Treatment Bibliography
|
Jan 25, 2026 |
|
Stiff Person Syndrome: Clinical Spectrum, Diagnosis, and Management
|
Jan 25, 2026 |
|
Management of Dementia with Lewy Bodies, A Review
|
Jan 25, 2026 |
|
Seronegative Autoimmune Encephalitis
|
Jan 18, 2026 |
|
Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord
|
Jan 18, 2026 |
|
Distinguishing Vestibular Vertigo from Posterior Stroke
|
Jan 18, 2026 |
|
2025 In Review - MS and Autoimmune CNS Disorders
|
Dec 29, 2025 |
|
2025 In Review - Epilepsy
|
Dec 29, 2025 |
|
2025 In Review - Stroke and Neurovascular Disorders
|
Dec 29, 2025 |
|
2025 In Review - Movement Disorders
|
Dec 28, 2025 |
|
2025 In Review - Neuromuscular Disorders
|
Dec 28, 2025 |
|
GLP-1 Receptor Agonists: Efficacy, Safety, and Neurological Frontiers
|
Dec 28, 2025 |
|
Treating psychiatric comorbidities in patients with epilepsy.
|
Dec 21, 2025 |
|
The prognosis and treatment outcomes for individuals with focal epilepsy
|
Dec 20, 2025 |
|
Global surge of early-onset Parkinson’s disease (EOPD)
|
Dec 20, 2025 |
|
New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES)
|
Dec 20, 2025 |
|
Long-term outcomes of seizures and epilepsy in patients with untreated cerebral cavernous malformations
|
Dec 14, 2025 |
|
Phenotype-Genotype Correlations in Myelin Protein Zero (MPZ) Variants
|
Dec 14, 2025 |
|
Cardiac Involvement in Myotonic Dystrophy Type 1 and 2
|
Dec 13, 2025 |
|
Rituximab Therapy for Resistant Myasthenia Gravis
|
Dec 07, 2025 |
|
Advances in Treatment of Myasthenia Gravis
|
Nov 30, 2025 |
|
Peripheral Neuropathy: A Comprehensive Review
|
Nov 23, 2025 |
|
Diagnostic Controversies in Chronic Inflammatory Demyelinating Polyneuropathy
|
Nov 16, 2025 |
|
Early Use of Rituximab in New-Onset Generalized Myasthenia Gravis: RINOMAX Trial
|
Nov 16, 2025 |
|
CAR-T cell therapy, neurological risks and potential use
|
Nov 09, 2025 |
|
Active Inference Model of Functional Neurological Disorder
|
Nov 02, 2025 |
|
Are COVID-19, RSV, and Influenza vaccines safe and effective?
|
Nov 02, 2025 |
|
Outcome Measures for Adult Becker Muscular Dystrophy Progression
|
Oct 20, 2025 |
|
2025 ILAE 2025 updated seizure classification
|
Oct 19, 2025 |
|
Myasthenia Gravis 2025 Updated Management Guidelines from the Association of British Neurologists
|
Oct 15, 2025 |
|
Iatrogenic Cerebral Amyloid Angiopathy (CAA) and CAA related inflammation (CAA-ri)
|
Oct 15, 2025 |
|
Early Tirofiban After Thrombolysis for Ischemic Stroke (ASSET-IT trial)
|
Oct 06, 2025 |
|
Friedreich’s ataxia - A Comprehensive Look
|
Oct 05, 2025 |
|
CADASIL Unmasked
|
Oct 05, 2025 |
|
TTR Familial Amyloidosis Genotype-Phenotype Correlation
|
Sep 28, 2025 |
|
Spinal Bulbar Muscular Atrophy: Canadian Best Practice Recommendations
|
Sep 24, 2025 |
|
2025 Revised Criteria for Vascular Cognitive Impairment
|
Sep 21, 2025 |
|
Idiopathic Normal Pressure Hydrocephalus: Incidence, Progression, Diagnosis and Treatment
|
Sep 21, 2025 |
|
Glycine Receptor Antibody Associated Progressive Encephalomyelitis Clinical Outcomes (PREM)
|
Sep 21, 2025 |
|
Neurological complications of drug misuse
|
Sep 14, 2025 |
|
Minimally invasive surgery for intracerebral hemorrhage
|
Sep 14, 2025 |
|
A blood test to distinguish Parkinson's disease and Dementia with Lewy bodies
|
Sep 07, 2025 |
|
Navigating Postanoxic Status Epilepticus
|
Sep 07, 2025 |
|
Migraine Prevention Review: Therapies, Efficacy, and Safety
|
Sep 07, 2025 |
|
Using serum NFL and antibody titer to monitor disease activity in CASPR2/LGI1 autoimmune encephalitis
|
Sep 06, 2025 |
|
Peripheral blood monocytes can predict impending relapses and disability worsening in MS
|
Sep 06, 2025 |
|
Late Effects of Traumatic Brain Injury
|
Aug 17, 2025 |
|
Oseltamivir Reduces Pediatric Neuropsychiatric Events During Influenza
|
Aug 10, 2025 |
|
Health Anxiety in Neurological Settings
|
Aug 02, 2025 |
|
Laser interstitial thermal therapy for mesial temporal lobe epilepsy
|
Jul 20, 2025 |
|
Myasthenia Gravis Autoantibody Heterogeneity and Therapeutic Implications
|
Jul 20, 2025 |
|
VCP Multisystem Proteinopathy
|
Jul 20, 2025 |
|
Updated AAN Guidelines on prolonged disorders of consciousness
|
Jul 14, 2025 |
|
Psychiatric comorbidities are an independent risk factor for unfavorable outcomes in Autoimmune Encephalitis
|
Jul 13, 2025 |
|
Timing of Anticoagulation for Stroke and Atrial Fibrillation
|
Jul 05, 2025 |
|
Treating Small Vessel CNS Vasculitis: Early Intervention and Remission
|
Jul 05, 2025 |
|
Neurofilament Light Chain Assays in MS Management
|
Jun 23, 2025 |
|
Nucleoside reverse transcriptase inhibitor use and reduced risk of Alzheimer’s disease
|
Jun 18, 2025 |
|
Lipoprotein a and Stroke Recurrence: A Systematic Review
|
Jun 15, 2025 |
|
Serum NFL as a biomarker for CIDP Diagnosis and Treatment
|
Jun 08, 2025 |
|
Upadacitinib for Giant-Cell Arteritis, SELECT-GCA Trial Results
|
Jun 04, 2025 |
|
Assessing Functional Motor Weakness: A Practical Guide
|
Jun 01, 2025 |
|
Treating Neuropsychiatric Symptoms in Parkinson's Disease
|
Jun 01, 2025 |
|
Rituximab Use in Anti-NMDAR Antibody-Mediated Encephalitis Relapse Prevention
|
Jun 01, 2025 |
|
Understanding Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders
|
May 25, 2025 |
|
Repeat Expansion Disorders in Neurology
|
May 23, 2025 |
|
Neurological IgG4-Related Disease: Diagnosis and Management
|
May 23, 2025 |
|
Long-Term Ravulizumab Efficacy and Safety in Generalized Myasthenia Gravis
|
May 23, 2025 |
|
The Second European Carotid Surgery Trial (ECST-2)
|
May 11, 2025 |
|
Inebilizumab Trial in Myasthenia Gravis
|
May 06, 2025 |
|
Brain MRI as prognostic factor in Anti NMDA Encephalitis
|
May 03, 2025 |
|
Efgartigimod Efficacy and Safety in CIDP - ADHERE and ADHERE+ Trials
|
May 02, 2025 |
|
Telitacicept Shows Strong Efficacy for Generalized Myasthenia Gravis
|
Apr 27, 2025 |
|
C5 vs FcRn inhibitors for generalized myasthenia gravis
|
Apr 27, 2025 |
|
MMF for anti-NMDA antibody maintenance
|
Apr 27, 2025 |
|
European Guidelines for Assessment and Management of Neurogenic Bladder
|
Apr 20, 2025 |
|
ADVANCE CIDP -IVIG Clinical Trial
|
Apr 20, 2025 |
|
Multifocal Motor Neuropathy - A Comprehensive Review
|
Apr 12, 2025 |
|
Bone marrow transplantation for MS, ECTRIMS Recommendation
|
Apr 12, 2025 |
|
Do glucose lowering drugs prevent dementia?
|
Apr 12, 2025 |
|
Serum NfL as a Diagnostic and Prognostic ALS Biomarker
|
Apr 06, 2025 |
|
Stress and cryptogenic stroke in young adults
|
Apr 06, 2025 |
|
Using AI Vision in Neurology
|
Mar 30, 2025 |
|
European Guidelines on PET imaging for brain metastasis
|
Mar 29, 2025 |
|
Pyridostigmine for Orthostatic Hypotension
|
Mar 29, 2025 |
|
MoCA vs MMSE for Frontotemporal Dementia
|
Mar 23, 2025 |
|
Prognosis of Postanoxic Status Epilepticus
|
Mar 23, 2025 |
|
Idiopathic intracranial hypertension - diagnosis
|
Mar 23, 2025 |
|
rTMS Trial for Cognitive Impairment in ALS
|
Mar 22, 2025 |
|
Rozanolixizumab in Generalized Myasthenia Gravis - OLE
|
Mar 22, 2025 |
|
CSF-Serum Free Kappa Light Chain Index - Optic Neuritis Diagnosis
|
Mar 16, 2025 |
|
ABN Guidelines on Multiple Sclerosis Disease-Modifying Treatment
|
Mar 15, 2025 |
|
Neurological complications of immune checkpoint inhibitors
|
Mar 15, 2025 |
|
TMPN Trial in ALS
|
Mar 13, 2025 |
|
A Practical Approach to the Diagnosis of Neuropathies
|
Mar 13, 2025 |
|
Therapeutics in Inflammatory Muscle Diseases
|
Mar 09, 2025 |
|
Treatment of Cluster Headaches
|
Mar 09, 2025 |
|
Clinical Trial of Zilucoplan in ALS
|
Mar 09, 2025 |
|
Is Multiple Sclerosis a Virus-Induced Gliopathy?
|
Mar 08, 2025 |
|
DDPX Antibody Associated Encephalitis - A Review
|
Mar 05, 2025 |
|
Antidepressant use and cognitive decline in patients with dementia: a national cohort study
|
Mar 02, 2025 |
|
Cost of New Neurologic Medications
|
Mar 01, 2025 |
|
rTMS and Aphasia Therapy Post-Stroke, a Clinical Trial
|
Mar 01, 2025 |
|
Periodic EEG Patterns
|
Feb 24, 2025 |
|
Acceptance and Commitment Therapy
|
Feb 24, 2025 |
|
Endovascular therapy versus best medical care for acute ischemic stroke with distal medium vessel occlusion
|
Feb 23, 2025 |
|
Exenatide in Parkinson’s disease phase 3 trial
|
Feb 23, 2025 |
|
No long‑term benefits from resistance training on brain grey matter volumes in active older adults at retirement age
|
Feb 23, 2025 |
|
Tirofiban Efficacy in Stroke
|
Feb 09, 2025 |
|
International Consensus Guidance for Managing Glucocorticoid-Related Neuromuscular Complications
|
Feb 09, 2025 |
|
Consensus Statement on Continuous EEG in Critically Ill Patients
|
Feb 02, 2025 |
|
AI-Optimized Anti-Seizure Treatment and EEG in Brain Injury
|
Feb 02, 2025 |
|
MOG Antibody Testing in Clinical Practice
|
Feb 02, 2025 |
|
LUMINESCE A phase 3 trial clinical trial of satralizumab for generalized myasthenia gravis
|
Feb 02, 2025 |
|
Lipid Variability and Cognitive Decline in Older Adults
|
Feb 02, 2025 |
|
Blood Biomarkers and MS Diagnosis
|
Feb 02, 2025 |
|
Long-Term Ocrelizumab Treatment for Early-Stage Relapsing MS
|
Feb 02, 2025 |
|
The Spectrum of Genetic Risk in Alzheimer's Disease
|
Feb 02, 2025 |
|
Central Nervous System Manifestations in Sjögren's Disease
|
Jan 26, 2025 |
|
Intravenous Thrombolysis for Minor Stroke - A Systematic Review and Meta-analysis
|
Jan 26, 2025 |
|
Cancer risk in multiple sclerosis patients and DMT
|
Jan 26, 2025 |
|
Neurogenic Orthostatic Hypotension in Parkinson's Disease
|
Jan 26, 2025 |
|
Cognitive decline after heart failure
|
Jan 26, 2025 |
|
Friedreich Ataxia: A 30-Year Retrospective
|
Jan 20, 2025 |
|
Breaking Bad News in ALS/MND: The A-L S-PIKES Protocol
|
Jan 19, 2025 |
|
Plasma Neurofilaments as ALS Biomarkers
|
Jan 19, 2025 |
|
APOE's Role in Cerebral Amyloid Angiopathy
|
Jan 19, 2025 |
|
Intra-arterial Tenecteplase After Posterior Circulation Recanalization - ATTENTION-IA trial
|
Jan 18, 2025 |
|
WHO Classification of Central Nervous System Tumors, Fifth Edition - A flashback to 2021
|
Jan 16, 2025 |
|
Tele-EEG for Critically Ill Patients: A Multicenter RCT
|
Jan 12, 2025 |
|
CRISPR-Cas9 Gene Editing for ATTR Cardiomyopathy
|
Jan 11, 2025 |
|
SAHARA Trial: Transfusion Strategies in Aneurysmal Subarachnoid Hemorrhage
|
Jan 11, 2025 |
|
Anti-IgLON5 Disease: A Decade of Discovery and Unanswered Questions
|
Jan 11, 2025 |
|
Autoimmune Nodopathies and IgG4 Antibodies in Neurology
|
Jan 11, 2025 |
|
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study
|
Jan 11, 2025 |
|
Introduction to Weekly Deep Dive Neurology Podcast
|
Jan 05, 2025 |
|
Memantine in Amyotrophic Lateral Sclerosis
|
Jan 04, 2025 |
|
Rituximab for Idiopathic Inflammatory Myositis: A Systematic Review and Meta-analysis
|
Jan 04, 2025 |
|
Vutrisiran for ATTR cardiomyopathy
|
Jan 04, 2025 |
|
Long-Term Safety of fSCIG for CIDP Maintenance Therapy
|
Jan 04, 2025 |
|
Neurofilament Light Chain and GFAP in Mood and Anxiety Disorders
|
Jan 04, 2025 |
|
Efficacy and Safety of IVIG Maintenance Therapy in Generalized Myasthenia Gravis
|
Jan 04, 2025 |
|
Anticoagulation strategy for patients presenting with ischemic strokes while using a direct oral anticoagulant:
|
Jan 04, 2025 |
|
Early Atogepant Efficacy in Migraine Prevention
|
Dec 29, 2024 |
|
2024 AASM Clinical Practice Guideline: Restless Legs Syndrome and PLMD Treatment
|
Dec 29, 2024 |